$11.340
-0.196 (-1.73%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
SLS Prediction & Forecast by Similar Chart Analysis
Alphio's SLS stock price prediction model matches the current Sellas Life Sciences Group Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.43 (+0.75%). The 1-week path is $11.64 (+2.67%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Sellas Life Sciences Group Inc Stock?
Sellas Life Sciences Group Inc is a good buy right now, trading at $11.54 with a strong year-to-date change of +165.29% and a 1-year change of +494.85%. The upcoming Regal trial results are critical, as they could significantly impact the stock price, with analysts projecting a target price up to $35. However, investors should be cautious of the company's ongoing net losses, which are expected to reach -$9,605,000 in Q2 2026, indicating financial instability.
SLS stock price ended at $11.34 on Monday, after losing -1.73%
Sellas Life Sciences Group Inc (SLS) last closed at $11.3400002, losing -1.73%. These facts feed the 1-day and 1-week SLS price prediction above.
Forecast Drivers
Sellas Life Sciences Group Inc (SLS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches SLS, ranked by similarity.
Seasonality analysis for SLS
Historically the probability of a positive October return for SLS is 100.00%. May offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for SLS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $1.82 | $2.14 | $2.32 | -81.15% |
| Nov 2026 | $1.65 | $1.71 | $2.11 | -84.95% |
| Dec 2026 | $1.55 | $1.58 | $1.80 | -86.07% |
In 2026, Sellas Life Sciences Group Inc (SLS) is projected to range from $1.55 to $2.32.
Sellas Life Sciences Group Inc 2026 monthly forecast
In Oct 2026, Sellas Life Sciences Group Inc is projected to average $2.14, with a low of $1.82 and high of $2.32.
In Nov 2026, Sellas Life Sciences Group Inc is projected to average $1.71, with a low of $1.65 and high of $2.11.
In Dec 2026, Sellas Life Sciences Group Inc is projected to average $1.58, with a low of $1.55 and high of $1.80.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.